Attacking Metastatic Tumors in the Brain

Targeting HER3 could cripple metastatic cancers that have spread to the brain. (Bethesda, MD, June 5, 2017) Rakesh Jain, PhD, Director of the Edwin L. Steele Laboratory for Tumor Biology at the Massachusetts General Hospital and supported by the National…

Read more

Non-Invasive Liquid Biopsy Uncovers Key Information to Treat Cancer

A liquid biopsy can provide valuable insight into how to best fight cancer. This noninvasive diagnostic is particularly helpful for patients who cannot undergo a surgical biopsy or whose tumor sample has been exhausted. In the not-too-distant future, liquid biopsies…

Read more

Meet Carmen Rice: A Courageous and Inspirational GBM Survivor

This year marks the 13th anniversary of Carmen Rice’s survival from Glioblastoma Multiforme (GBM) – the deadliest brain cancer that is widely regarded as incurable and universally fatal. GBM kills 91% of patients within three years of diagnosis and NFCR…

Read more

Highlights of ASCO 2017

Founded in 1964, the American Society of Clinical Oncology (ASCO®) is the world’s leading professional organization for physicians and oncology professionals caring for people with cancer. Each year, tens of thousands of oncology professionals, cancer researchers and patient advocates gather…

Read more

Simple, Sensational Cancer-Fighting Salsa

Snacking on salsa is a simple and tasty way to add cancer-fighting fruits and veggies to your diet.  With a variety of ingredients from tomatoes, jalapenos or habanero peppers to mangoes, pineapples, strawberries and even beans, salsa can spice up…

Read more

4 Must-Know Facts About the Deadliest Brain Tumor

Glioblastoma multiforme—also known as GBM—is the most lethal form of brain cancer in adults. This devastating brain cancer spreads into other parts of the brain very quickly and is usually not surgically curable. Typically, radiation and chemotherapy are given with…

Read more

7 Facts You Need to Know About Brain Tumors

What is Brain Tumor? Of the nearly 80,000 brain tumors diagnosed in the U.S. each year, approximately 32% are considered malignant – or cancerous. Overall, the chance that a person will develop a malignant tumor of the brain or spinal…

Read more

2017 Szent-Györgyi Prize for Progress in Cancer Research Awarded to Michael N. Hall

More than 170 guests enjoyed a fabulous Monday evening at the National Press Club recognizing Michael N. Hall, Ph.D., Professor of Biochemistry at the Biozentrum of the University of Basel in Switzerland, as the 2017 recipient of the Szent-Györgyi Prize…

Read more

8 Facts You Need to Know About Skin Cancer

May is National Skin Cancer Prevention and Detection Month and Melanoma Awareness Month. As skin cancer is the most common type of cancer in the U.S. and the most treatable, when caught early, it’s important to understand what you can…

Read more

Improving the Delivery and Efficacy of Anti-Cancer Therapeutics

In honor of National Medical Laboratory Professional Week, we’d like to highlight a few of the many accomplishments of NFCR-funded scientist, Dr. Rakesh Jain. About Dr. Rakesh Jain Rakesh K. Jain, Ph.D., Andrew Werk Cook professor of tumor biology (radiation…

Read more

Understanding Adaptive Clinical Trials

Testing new treatments is key to successfully treating cancer. Unfortunately, the current model for conducting clinical trials — evaluating the effectiveness of therapies on human subjects — is inefficient, expensive and suffers from high failure rates. To overcome these challenges, the…

Read more

The Pioneering Gene Work of Dr. Mary-Claire King

The Szent-Györgyi Prize was established in honor of Nobel laureate Dr. Albert Szent-Györgyi, co-founder of NFCR, to recognize outstanding scientific achievement in the war against cancer. Ten years later, “ASG Winners: Then & Now” looks at these winners, their extraordinary…

Read more